Company Description

Morphocell Technologies is a regenerative medicine company developing stem cell–derived tissue and organ replacement therapies. Its proprietary allogeneic platform is designed to address severe organ deficiencies, beginning with liver disease. The company’s lead product, ReLiver®, is an off-the-shelf engineered liver tissue intended to temporarily replace liver function and enable regeneration without the need for immunosuppression.